Viatris | Umsatzkosten



Cost Of Sales Veränderung Datum
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Celltrion KRW 399.04B 120.81B 2025-03
Cspc Pharmaceutical CNY 2.31B 299.94M 2025-03
Divis Laboratories Ltd 10.68B 870M 2025-06
Kangmei Pharma CNY 1.03B 35.75M 2025-06
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 54.41M 97.64M 2025-06
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 5.27M 2.92M 2024-12
Organigram Holdings CAD 44.65M 2.96M 2025-06
Pharma Mar EUR 2.78M 620K 2025-06
Qiagen NV USD 199.25M 24.48M 2025-06
Sartorius EUR 468.1M 16.1M 2025-06
Sino Biopharmaceutical CNY 2.49B 353.34M 2024-12
Tilray USD 149.73M 9.39M 2024-11
Viatris USD 2.25B 229.7M 2025-06
Zz Pientze Pharmaceu 1.94B 214.76M 2025-06


Viatris Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.